Oana Sandulescu

Dr. Oana Sandulescu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2019 in Discoveries
Verified
Journal Article
Open access
VPVeronica Georgiana Preda
Veronica Georgiana Preda
Oana SandulescuOana Sandulescu
Oana Sandulescu
Antibiotic resistance is a relevant topic nowadays, representing one of the main causes of infection-related mortality and morbidity at a global level. This phenomenon is worrisome and represents an area of interest for both clinical practice and fundamental research. One important mechanism whereby bacteria acquire resistance to antibiotics and evade the immune system is by forming biofilms. It is estimated that ~80% of the bacteria producing chronic infections can form biofilms. During the process of biofilm formation microorganisms have the ability to communicate with each other through quorum sensing. Quorum sensing regulates the metabolic activity of planktonic cells, and it can induce microbial biofilm formation and increased virulence. In this review we describe the biofilm formation process, quorum sensing, quorum quenching, several key infectious bacteria producing biofilm, methods of prevention and their challenges and limitations. Although progress has been made in the prevention and treatment of biofilm-driven infections, new strategies are required and have to be further developed.

30 January 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMarius Surleac
Marius Surleac
IBIlda Czobor Barbu
Ilda Czobor Barbu
SPSimona Paraschiv
Simona Paraschiv
LPLaura Ioana Popa
Laura Ioana Popa
IGIrina Gheorghe
Irina Gheorghe
MCMariana Carmen Chifiriuc
Mariana Carmen Chifiriuc
We report on the genomic characterization of 47 multi-drug resistant, carbapenem resistant and ESBL-producing K. pneumoniae isolates from the influent (I) and effluent (E) of three wastewater treatment plants (WWTPs) and from Romanian hospital units which are discharging the wastewater in the sampled WWTPs. The K. pneumoniae whole genome sequences were analyzed for antibiotic resistance genes (ARGs), virulence genes and sequence types (STs) in order to compare their distribution in C, I and E samples. Both clinical and environmental samples harbored prevalent and widely distributed ESBL genes, i.e. blaSHV, blaOXA, blaTEM and blaCTX M. The most prevalent carbapenemase genes were blaNDM-1, blaOXA-48 and blaKPC-2. They were found in all types of isolates, while blaOXA-162, a rare blaOXA-48 variant, was found exclusively in water samples. A higher diversity of carbapenemases genes was seen in wastewater isolates. The aminoglycoside modifying enzymes (AME) genes found in all types of samples were aac(6’), ant(2'')Ia, aph(3'), aaD, aac(3) and aph(6). Quinolone resistance gene qnrS1 and the multi-drug resistance oqxA/B pump gene were found in all samples, while qnrD and qnrB were associated to aquatic isolates. The antiseptics resistance gene qacEdelta1 was found in all samples, while qacE was detected exclusively in the clinical ones. Trimethroprim-sulfamethoxazole (dfrA, sul1 and sul2), tetracyclines (tetA and tetD) and fosfomycin (fosA6, known to be located on a transpozon) resistance genes were found in all samples, while for choramphenicol and macrolides some ARGs were detected in all samples (catA1 and catB3 / mphA), while other (catA2, cmIA5 and aac(6’)Ib / mphE and msrE) only in wastewater samples. The rifampin resistance genes arr2 and 3 (both carried by class I integrons) were detected only in water samples. The highly prevalent ARGs preferentially associating with aquatic versus clinical samples could ascribe potential markers for the aquatic (blaSHV-145, qacEdelta1, sul1, aadA1, aadA2) and clinical (blaOXA-1, blaSHV-106,blaTEM-150, aac(3)Iia, dfrA14, oqxA10; oqxB17,catB3, tetD) reservoirs of AR. Moreover, some ARGs (oqxA10; blaSHV-145; blaSHV-100, aac(6')Il, aph(3')VI, armA, arr2, cmlA5, blaCMY-4, mphE, msrE, oqxB13, blaOXA-10) showing decreased prevalence in influent versus effluent wastewater samples could be used as markers for the efficiency of the WWTPs in eliminating AR bacteria and ARGs. The highest number of virulence genes (75) was recorded for the I samples, while for E and C samples it was reduced to half. The most prevalent belong to three functional groups: adherence (fim genes), iron acquisition (ent, fep, fyu, irp and ybt genes) and the secretion system (omp genes). However, none of the genes associated with hypervirulent K. pneumoniae have been found. A total of 14 STs were identified. The most prevalent clones were ST101, ST219 in clinical samples and ST258, ST395 in aquatic isolates. These STs were also the most frequently associated with integrons. ST45 and ST485 were exclusively associated with I samples, ST11, ST35, ST364 with E and ST1564 with C samples. The less frequent ST17 and ST307 aquatic isolates harbored blaOXA-162, which was co-expressed in our strains with blaCTX-M-15 and blaOXA-1.

1 February 2017 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
CPCéline Pulcini
Céline Pulcini
GTGianpiero Tebano
Gianpiero Tebano
NMNico T Mutters
Nico T Mutters
ETEvelina Tacconelli
Evelina Tacconelli
ECEmmanuelle Cambau
Emmanuelle Cambau
VLViktor Liashko
Viktor Liashko

23 August 2021 in Clinical Therapeutics
Verified
Journal Article
Closed access
JKJin Yong Kim
Jin Yong Kim
YJYoung Rock Jang
Young Rock Jang
JHJang Hee Hong
Jang Hee Hong
JJJin Gyu Jung
Jin Gyu Jung
JPJae-Hyeong Park
Jae-Hyeong Park
YKYeon-Sook Kim
Yeon-Sook Kim

2 January 2022 in Expert Opinion on Investigational Drugs
Verified
Journal Article
Closed access
EMEnrique Miguez-Rey
Enrique Miguez-Rey
DCDasom Choi
Dasom Choi
SKSeungmin Kim
Seungmin Kim
SYSangwook Yoon
Sangwook Yoon
Oana SandulescuOana Sandulescu
Oana Sandulescu
Neutralizing antibodies (NAbs) that target key domains of the spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may have therapeutic value because of their specificity. ...

9 November 2020 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
Constantinos TsioutisConstantinos Tsioutis
Constantinos Tsioutis
GBGabriel Birgand
Gabriel Birgand
EBErik Bathoorn
Erik Bathoorn
ADAleksander Deptula
Aleksander Deptula
LHLenny Ten Horn
Lenny Ten Horn
NMNico T Mutters
Nico T Mutters
Background: Studies have repeatedly highlighted the need for homogenisation of training content and opportunities in infection prevention and control (IPC) across European countries. Objectives: To map current training opportunities for IPC professionals, define local needs and highlight differences, across 11 European countries (Cyprus, France, England, Germany, Greece, Italy, Netherlands, Poland, Romania, Spain, Switzerland). Sources: From July 2018 to February 2019, IPC experts directly involved in IPC training and education in their countries and/or internationally were invited to complete a prespecified set of questions in order to provide a detailed description of IPC training opportunities and needs in their country. Conclusions: IPC training among nurses and doctors varies greatly across countries, with differences in content and type of training (e.g., standardised curriculum, educational programme, clinical experience) duration, as well as in assessment and recognition/accreditation. The observed heterogeneity in IPC training between European countries can be eliminated through establishment of interdisciplinary region-wide training programmes, with common learning objectives, shared know-how and supported by national and international professional bodies.